Clinical Trials Directory

Trials / Unknown

UnknownNCT05251792

Macular Pigment Optical Density in Primary Angle-closure Disease

Study on the Relationship Between Macular Pigment Optical Density and Primary Angle-closure Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Accepted

Summary

Glaucoma is the leading cause of irreversible blindness in the world, and primary angle-closure glaucoma (PACG) is the most important type of glaucoma in Asia. Primary angle closure disease (PACD) is a group of diseases related to PACG, and the pathogenesis is still unclear. Macular pigment has the functions of filtering short-wavelength waves and anti-oxidation, which are related to visual function. Previous studies have found that the macular pigment density (MPOD) is significantly reduced in primary open-angle glaucoma. This project uses the single-wavelength reflection method to measure MPOD, observes the characteristics of PACD and the normal control group's changes in retinal MPOD, and explains the relationship between PACD's MPOD changes and angle-closure glaucoma optic nerve damage

Detailed description

Observation index: Visual acuity,Intraocular pressure,Ophthalmoscope,MPOD,Visual field and OCT. Inspection parameters of OCT: 1. Retinal nerve fiber layer thickness 2. Ganglion cell complex thickness 3. Mean thickness of the central retina 4. Mean defect

Conditions

Interventions

TypeNameDescription
OTHEROcular examinationAll participants underwent a detailed examination, including visual acuity, slit lamp biomicroscopy, direct ophthalmoscopy, optometry noncontact tonometry,MPOD measurement and optical coherence tomography (OCT) measurement

Timeline

Start date
2021-11-11
Primary completion
2024-03-30
Completion
2024-12-30
First posted
2022-02-23
Last updated
2023-02-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05251792. Inclusion in this directory is not an endorsement.